Los Altos, CA, United States of America

Christopher R Wagstrom


Average Co-Inventor Count = 8.7

ph-index = 8

Forward Citations = 413(Granted Patents)


Company Filing History:


Years Active: 1999-2012

Loading Chart...
10 patents (USPTO):

Title: **Innovative Contributions of Christopher R. Wagstrom**

Introduction

Christopher R. Wagstrom is a prominent inventor based in Los Altos, California. He has a substantial portfolio of ten patents, showcasing his significant contributions to the field of medicinal chemistry and biotechnology. His work primarily focuses on developing peptides and compounds that target specific receptors, particularly in treating hematological disorders.

Latest Patents

Among his latest patents are innovations related to peptides and peptide mimetics that specifically bind to and activate the thrombopoietin receptor. These discoveries are particularly impactful in treating thrombocytopenia, a condition that can arise from chemotherapy, radiation therapy, or bone marrow transfusions. Wagstrom's research holds promise for advancing diagnostic methods utilizing labeled peptides and peptide mimetics.

Career Highlights

Throughout his career, Christopher R. Wagstrom has worked with notable companies, including Glaxo Wellcome Inc. and Glaxo Group Limited. His experience in these organizations has allowed him to contribute to groundbreaking research and development in pharmaceuticals, particularly in the area of hematology.

Collaborations

Wagstrom has collaborated with distinguished colleagues such as William J. Dower and Ronald W. Barrett. These collaborations have facilitated the exchange of ideas and expertise, significantly contributing to the advancements made in their shared field of research.

Conclusion

Christopher R. Wagstrom is a key figure in the invention of novel peptides and methods for addressing critical medical issues. His innovations continue to impact the landscape of treatments for hematological disorders, reinforcing the essential role of inventors in the advancement of healthcare solutions. As he continues his work, the scientific community eagerly awaits his future contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…